A Beta₂-Agonist, Procaterol, Inhibits Basophil Migration

References

• Dolovich J, Hargreave F E, Chalmers R, Shier K J, Gauldie J, Bienenstock J. Late cutaneous allergic responses in isolated IgE-dependent reactions. J. Allergy Clin Immunol 1973; 52: 38
   PubMed Web of Science ®Google Scholar
• Lemanske R F, Jr, Kaliner M. Late-phase IgE-mediated reactions. J Clin Immunol 1988; 8: 1
   Google Scholar
• De Monchy J GR, Kauffman H F, Venge P, Koëter G H, Jansen H M, Sluiter H J, De Vries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373
   PubMed Web of Science ®Google Scholar
• Bascom R, Pipkorn U, Proud D, Dunnette S, Gleich G J, Lichtenstein L M, Naclerio R M. Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: Effect of systemic corticosteroids and relationship to eosinophil influx. J Allergy Clin Immunol 1989; 84: 338
   Google Scholar
• Bascom R, Wachs M, Naclerio R M, Pipkorn U, Galli S J, Lichtenstein L M. Basophil influx occurs after nasal antigen challenge: Effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988; 81: 580
   PubMed Web of Science ®Google Scholar
• Charlesworth E N, Kagey-Sobotka A, Norman P S, Lichtenstein L M. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 1989; 83: 905
   PubMed Web of Science ®Google Scholar
• Charlesworth E N, Hood A F, Soter N A, Kagey-Sobotka A, Norman P S, Lichtenstein L M. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 1989; 83: 1519
   PubMed Web of Science ®Google Scholar
• Iliopoulos O, Baroody F M, Naclerio R M, Bochner B S, Kagey-Sobotka A, Lichtenstein L M. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol 1992; 148: 2223
   PubMed Web of Science ®Google Scholar
• Naclerio R M, Proud D, Togias A G, Adkinson N F, Jr, Meyers D A, Kagey-Sobotka A, Plaut M, Norman P S, Lichtenstein L M. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985; 313: 65
   PubMed Web of Science ®Google Scholar
• Persson C GA, Erjefält I, Grega G J, Svensjö E. The role of beta-receptor agonists in the inhibition of pulmonary edema. Ann NY Acad Sci 1982; 384: 544
   PubMed Web of Science ®Google Scholar
• Twentyman O P, Finnerty J P, Holgate S T. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma. Am Rev Respir Dis 1991; 144: 782
   Google Scholar
• Twentyman O P, Finnerty J P, Harris A, Palmer J, Holgate S T. Protection against allergen-induced asthma by salmeterol. Lancet 1990; 336: 1338
   PubMed Web of Science ®Google Scholar
• Grönneberg R, Zetterström O. Inhibitory effects of formoterol and terbutaline on the development of late phase skin reactions. Clin Exp Allergy 1992; 21: 257
   Google Scholar
• Yamaguchi M, Hirai K, Morita Y, Takaishi T, Ohta K, Suzuki S, Motoyoshi K, Kawanami O, Ito K. Hemopoietic growth factors regulate the survival of human basophils in vitro. Int Arch Allergy Immunol 1992; 97: 322
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Hirai K, Shoji S, Takaishi T, Ohta K, Morita Y, Suzuki S, Ito K. Haemopoietic growth factors induce human basophil migration in vitro. Clin Exp Allergy 1992; 22: 379
   Google Scholar
• Johnson M, Vardey C J, Whelan C J. The therapeutic potential of long-acting betaO-adrenoreceptor agonists in allergic inflammation. Clin Exp Allergy 1992; 22: 177
   Google Scholar
• Whelan C J, Johnson M. Salmeterol inhibits granulocyte accumulation in guinea-pig lung. Br Pharmacol Soc 1991; 102: 176
   Google Scholar
• Sugiyama H, Okada C, Bewtra A K, Hopp R J, Townley R G. The effect of formoterol on the late asthmatic phenomena in guinea pigs. J Allergy Clin Immunol 1992; 89: 858
   Google Scholar
• Liu M C, Hubbard W C, Proud D, Stealey B A, Galli S J, Kagey-Sobotka A, Bleecker E R, Lichtenstein L M. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis 1991; 144: 51
   PubMed Web of Science ®Google Scholar
• Koshino T, Teshima S, Fukushima N, Takaishi T, Hirai K, Miyamoto Y, Arai Y, Sano Y, Ito K, Morita Y. Identification of basophils by immuno-histochemistry in the airways of postmortem cases of fatal asthma. Clin Exp Allergy 1993; 23: 919
   Google Scholar
• Hirai K, Morita Y, Misaki Y, Ohta K, Takaishi T, Suzuki S, Motoyoshi K, Miyamoto T. Modulation of human basophil histamine release by hemopoietic growth factors. J. Immunol 1988; 141: 3958
   PubMed Web of Science ®Google Scholar
• Hirai K, Yamaguchi M, Misaki Y, Takaishi T, Ohta K, Morita Y, Ito K, Miyamoto T. Enhancement of human basophil histamine release by interleukin 5. J Exp Med 1990; 172: 1525
   PubMed Web of Science ®Google Scholar
• Hirai K, Miyamasu M, Yamaguchi M, Nakajima K, Ohtoshi T, Koshino T, Takaishi T, Morita Y, Ito K. Modulation of human basophil histamine release by insulin-like growth factors. J Immunol 1993; 150: 1503
   Google Scholar
• Leonard E J, Skeel A, Yoshimura T, Noer K, Kutvirt S, Epps D V. Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. J. Immunol 1990; 144: 1323
   PubMed Web of Science ®Google Scholar
• Lett-Brown M A, Boetcher D A, Leonard E J. Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor. J. Immunol 1976; 117: 246
   Google Scholar
• Yamaguchi M, Hirai K, Nakajima K, Ohtoshi T, Takaishi T, Ohta K, Morita Y, Ito K. Dexamethasone inhibits basophil migration. Allergy
   Google Scholar
• Schleimer R P, Davidson D A, Peters S P, Lichtenstein L M. Inhibition of basophil leukotriene release by antiinflammatory steroids. Int Arch Allergy Appl Immunol 1985; 77: 241
   Google Scholar
• Schleimer R P, Derse C P, Friedman B, Gillis S, Plaut M, Lichtenstein L M, MacGlashan D W, Jr. Regulation of human basophil mediator release by cytokines. 1. Interaction with antiinflammatory steroids. J Immunol 1989; 143: 1310
   PubMed Web of Science ®Google Scholar
• Charlesworth E N, Kagey-Sobotka A, Schleimer R P, Norman P S, Lichtenstein L M. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J. Immunol 1991; 146: 671
   PubMed Web of Science ®Google Scholar
• Peachell P T, MacGlashan D W, Lichtenstein L M, Schleimer R P. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol 1988; 140: 571
   PubMed Web of Science ®Google Scholar
• Busse W W, Sosman J M. Isoproterenol inhibition of isolated human neutrophil function. J Allergy Clin Immunol 1984; 73: 404
   PubMed Web of Science ®Google Scholar
• Yukawa T, Ukena D, Kroegel C, Chanez P, Dent G, Chung K F, Barnes P J. Beta2-adrenergic receptors on eosinophils. Binding and functional studies. Am Rev Respir Dis 1990; 141: 1446
   PubMedGoogle Scholar
• Morita Y, Miyamoto T. Fenoterol, a selective beta2-adrenergic agonist, and inhibition of IgE-mediated basophil histamine release. Allergy 1987; 42: 524
   Google Scholar